Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine

By Andrew J. Krentz, Robert J. Chilton

Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine is an informative and insightful resource that discusses the intricate relationship between metabolic disorders and cardiovascular disease. Authored by Andrew J. Krentz and Robert J. Chilton, this book provides a comprehensive overview of the basic science and pathophysiology of the diseases, latest research in pharmacological approaches, and translational therapeutic options.

The global prevalence of cardiometabolic disorders has been on the rise over the years, with estimates indicating that at least one in two adults worldwide have them. While metabolic disorders, such as type 2 diabetes, were initially viewed as independent risk factors for cardiovascular disease (CVD), more recent studies suggest that the two conditions are deeply intertwined. It is, therefore, crucial to understand the overlapping mechanisms and develop appropriate therapeutic interventions that can address the underlying pathophysiology of both diseases.

Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine provides readers with an in-depth understanding of the subject matter. With 530 pages, the book carefully analyzes the role of various lipid and glucose metabolism pathways in causing CVD and other cardiometabolic disorders. It also discusses the latest developments in the treatment of metabolic syndrome, obesity, the role of inflammation in disease progression, and lifestyle interventions that can help improve patient outcomes.

One of the main strengths of the book is the detailed analysis of the various pharmacological approaches that can enhance cardiovascular health in patients with metabolic disorders. The authors discuss in detail the role of metformin, GLP-1 receptor agonists, SGLT2 inhibitors, and insulin in reducing CVD risk in patients with diabetes. They also address some of the controversies surrounding some of these drugs, such as the cardiovascular safety of sulfonylureas and the risk of diabetic ketoacidosis with SGLT inhibitors.

In summary, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine is a must-read for clinicians, researchers, and students interested in this rapidly developing field. The book provides a thorough analysis of the complex relationship between metabolic disorders and CVD, the latest research in pharmacological interventions, and therapeutic options for patients. Its engaging writing style, combined with its comprehensive coverage of the topic, makes it an accessible and informative resource for all.

Ordering or purchasing the book is highly recommended for those seeking to expand their knowledge in the field of cardiovascular endocrinology and metabolism. Whether you are a healthcare provider looking to improve patient outcomes or a student studying the subject matter, Cardiovascular Endocrinology and Metabolism: Theory and Practice of Cardiometabolic Medicine is an invaluable resource. So, do not miss the opportunity to access this rich source of knowledge and enhance your understanding of this critical area of medicine.

Product Details

• Publisher ‏ : ‎ Academic Press; 1st edition (April 13, 2023)
• Language ‏ : ‎ English
• ‏ : ‎ 530 pages
• ISBN-10 ‏ : ‎ 0323999913
• ISBN-13 ‏ : ‎ 978-0323999915